GALIL MEDICAL LAUNCHES NEW FAMILY OF CRYOABLATION NEEDLES Arden Hills, MN—DATE October 5, 2015 — Galil Medical, the global leader in interventional oncology cryoablation technolo…Read More
Thomas, McNerney & Partners
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. The firm has offices in Stamford, Minneapolis, and San Francisco. For further information, please visit www.tm-partners.com.
The Vertical Group
Vertical Group is one of the largest venture capital firms in the United States focused on medical devices and biotechnology. The firm and its partners have founded or led investments in many of the most successful medical device companies of the past two decades including: SciMed Life Systems, Kyphon Inc., ev3 Inc., Ventana Medical Systems (NASDAQ: VMSI), Xomed Surgical Products, and American Medical Systems. For further information, please visit www.vertical-group.com.
Investor Growth Capital
Investor Growth Capital ("IGC") invests in healthcare and information technology companies in the US, Northern Europe and Asia and is the wholly owned venture capital arm of Investor AB. IGC’s 25 investment professionals manage a portfolio whose value exceeds USD $800 million from offices located in New York, Menlo Park, Beijing, Hong Kong, Tokyo, Stockholm and Amsterdam. For further information, please visit http://www.investorgrowthcapital.com.
Martin J. Emerson
Mr. Emerson has served as our President and CEO since joining Galil in 2008 and has a strong track record of over 25 years of accomplishments in the medical device industry. Prior to joining Galil Mr. Emerson served as President and Chief Executive Officer of American Medical Systems (AMS). During his tenure at AMS, he held executive roles including Vice President and General Manager of International, Executive Vice President of Global Sales and Marketing and Chief Operating Officer. Prior to joining AMS, he held senior roles in the overseas operations for several American-based companies including Baxter International and Boston Scientific. Mr. Emerson serves on the Boards of Wright Medical, Incisive Surgical and Vascular Solutions. Mr. Emerson holds a Bachelor of Science in Accounting from Marquette University.
Richard B. Emmitt
Mr. Emmitt is a founder of the Vertical Group, Inc. and has over 30 years in health care industry investment experience including venture capital, investment research, and investment banking. As an Investment Analyst with Cyrus J. Lawrence and F. Eberstadt, Mr. Emmitt was recognized as one of the leading experts on the health care industry by Institutional Investor Magazine. He currently serves on the Boards of Directors of American Medical Systems, Inc., BioSet, ENTrigue Surgical, Galil Medical, Incumed, Tepha and Tornier. He previously served on the Boards of Directors of ev3 Inc, OsteoBiologics Inc., SciMed Life Systems, Xomed Surgical Products and Wright Medical. Mr. Emmitt received a B.A. in Economics from Bucknell University and an M.B.A. from the Rutgers School of Business. www.vertical-group.com
Shelly Wall Lanning
Ms. Lanning has spent her entire career in the life sciences field, in strategic, operating and investment roles. For the past ten years she has made late stage healthcare private equity investments as part of the Morgan Stanley Venture Partners healthcare team (6+ years) and HealthCor Partners. Previously, she was a Senior Associate and Kauffman Fellow at Tullis-Dickerson & Co. Prior to the fellowship program, she worked on silicone breast implant litigation focusing on regulatory compliance, product development and manufacturing for medical devices. Her experience includes working in operations for an orthopedic medical device company and as a biotech research analyst at an investment management company. Ms. Lanning earned her M.B.A. in finance from the Wharton School at the University of Pennsylvania. She holds a degree in Physiology from the University of Minnesota. Ms. Lanning has been a Director of National Healing Corporation, Medsite and Trivirix International and was actively involved with Suros Surgical, pSivida, D-Pharm, and Solstice Neuroscience. http://www.investorgrowthcapital.com
James E. Thomas
Mr. Thomas is a co-founder of Thomas, McNerney & Partners and has been investing in health care companies since 1992. James previously headed Warburg Pincus LLC's medical technology private equity practice, where he had responsibility for investments in biotechnology, pharmaceutical, medical device and diagnostic companies. Prior to joining Warburg, James was a Vice President at Goldman Sachs International in London. He is currently a board member of CAS Medical Systems, Inc. (CASM), Clarus Therapeutics, Inc., Galil Medical Ltd., Keystone Dental, Inc. and Torax Medical, Inc. Historical investments include: American Medical Systems Holdings, Inc. (AMMD), Coley Pharmaceutical Group, Inc. (COLY sold to Pfizer), The Medicines Company (MDCO), NeXagen, Inc. (NXGN/NXTR sold to Gilead Sciences, Inc.),OsteoBiologics, Inc. (sold to Smith & Nephew plc), Oxford GlycoSciences, plc (OGSI sold to Celltech Group plc), Transkaryotic Therapies, Inc. (TKTX sold to Shire Pharmaceuticals Group plc), Visible Genetics, Inc. (VGIN sold to Bayer Corporation), Wright Medical Group, Inc. (WMGI), and Xomed Surgical Products, Inc. (XOMD sold to Medtronic, Inc.). James graduated magna cum laude with a B.S. in Economics from the Wharton School at the University of Pennsylvania and received an M.Sc. in Economics from the London School of Economics.
Ms. Tune joined Thomas, McNerney & Partners in 2003 from Piper Jaffray, where she was a health care analyst focused on medical technology companies. While at Piper, Kathy covered over 20 companies in the medical device, medical supply and diagnostic areas. Her background also includes experience in new product development at Solvay, S.A. (in a division that is now part of Pfizer). Projects at Solvay included the development of vaccines for the prevention of viral infections. Kathy was also a Senior Scientist in molecular biology at the University of Minnesota, where she worked on the development of molecular biology based assays for the detection of infectious agents. Kathy is currently a board member of Galil Medical LTD, CAS Medical Systems, Inc. (CASM) and VertiFlex, Inc. Kathy serves or has served in advisory roles to portfolio companies Torax Medical, Inc. and Atritech, Inc. She is also the President of the Mid-America Health Care Investors Network (MHIN), a member of the American Heart Association's Advancing Sciences Executive Leadership Team, and a member of the Advisory Board for the Carlson Fund Enterprises at the University of Minnesota's Carlson School of Management. Her educational background includes an M.S. degree in Microbiology from the University of Minnesota and an M.B.A. from the University of Minnesota's Carlson School of Management, where she was a Robert and Gail Buuck Scholar.
Galil Medical is a global leader in delivering innovative cryotherapy solutions. We focus primarily on the ablation of solid tumor cancers and nerve ablation for pain management. Our products address a range of cancers including kidney, lung, bone, liver and prostate as well as several local pain and nerve conditions. Our customers include multiple physician specialties — primarily Interventional Radiologists, Interventional Oncologists and Urologists.